Metastatic Urothelial Carcinoma: A Model Malignancy for Immune Checkpoint Blockade
The ASCO Post,
Advertisement “After several decades without advances, nivolumab is now the second drug to receive regulatory approval for the…
Advertisement “After several decades without advances, nivolumab is now the second drug to receive regulatory approval for the…
By Matthew Stenger Posted: 10/18/2016 10:20:21 AM Last Updated: 10/18/2016 10:20:21 AM Tweet this page Advertisement Response…
By The ASCO Post Posted: 11/15/2016 10:36:09 AM Last Updated: 11/15/2016 10:36:09 AM Tweet this page Advertisement Patients…
In the phase I/II CheckMate 032 trial reported in The Lancet Oncology, Padmanee Sharma, MD, of The University of Texas MD…